COMPASS Pathways plc
NASDAQCOMPASS Pathways enters the second half of August with a striking disconnect — the stock is up 13% on the week and has nearly doubled year-to-date, yet short sellers have been rebuilding positions at a pace not seen in months. The short-selling story is the most striking tension here. Estimated short interest has climbed roughly 70% over the past month, rising from around 8.3…
CMPS short interest surges 26.5% in one week to 10.8M shares, though availability remains ample at 375%, easing borrow pressure for sellers.
COMPASS Pathways enters the second half of August with a striking disconnect — the stock is up 13% on the week and has nearly doubled year-to-date, yet short sellers have been rebuilding positions at a pace not seen in…
CMPS heads into the week of July 8 with a wave of bullish analyst action reshaping the Street narrative — even as the stock pulls back 8% on the week and earnings loom on July 30. The analyst story is the standout this…
Snapshot as of 20 Sept 2026
Options traders have turned unanimously bullish on CMPS. The put-call ratio hit 0.12 on June 25 — the lowest on record and a z-score of -2.3 standard deviations below the 20-day mean. For every put traded, eight calls…
COMPASS Pathways reported Q1 earnings on May 13 that beat estimates and flagged an accelerated FDA review timeline, delivering a jolt to a stock that had already climbed 69% over the prior month — and leaving a…
COMPASS Pathways reports Q1 2026 results on May 7 after a month that has completely re-priced the stock — and the short-side has scrambled to keep up. Options positioning has actually turned more bullish into the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CMPS — free to start on ORTEX.
Sign up for free →Open CMPS on ORTEX